Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erwin Schultz

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 6, 2017
Intervalltherapie mit Vemurafenib beim malignen MelanomNicolai Treiber, Margit Anna Huber, Lars Alexander Schneider, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2004
T cell recognition of desmoglein 3 peptides in patients with pemphigus vulgaris and healthy individualsChristian M Veldman, Kerstin L Gebhard, Wolfgang Uter, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 12, 2023
VEXAS-Syndrome, a newly described autoinflammatory systemic disease with dermatologic manifestationsVera Baur, Johanna Stoevesandt, Axel Hueber, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 12, 2023
VEXAS-Syndrom, eine neu beschriebene autoinflammatorische Systemerkrankung mit dermatologischen ManifestationenVera Baur, Johanna Stoevesandt, Axel Hueber, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 16, 2026
Multibacillary Leprosy - a diagnostic and therapeutic challengeVera Baur, Christoph Lange, Axel Hueber, et al.
Melanoma Research|November 10, 2007
Targeted combined anti-inflammatory and angiostatic therapy in advanced melanoma: a randomized phase II trialAlbrecht Reichle, Thomas Vogt, Brigitte Coras, et al.
American Journal of Clinical Dermatology|November 14, 2024
Intravenous Immunoglobulin Therapy for Pyoderma Gangrenosum: A Multicenter Retrospective Analysis in 81 PatientsMoritz Ronicke, Lukas Sollfrank, Martin V Vitus, et al.
JCI Insight|April 20, 2017
Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patientsStefanie Gross, Michael Erdmann, Ina Haendle, et al.
Annals of Surgical Oncology|February 23, 2017
The Impact of Smoking on Sentinel Node Metastasis of Primary Cutaneous MelanomaMaris S Jones, Peter C Jones, Stacey L Stern, et al.
Cancers|February 27, 2026
COMBI-EU: Real-World Evidence on Adverse Event Management and Time on Therapy with Adjuvant Dabrafenib Plus Trametinib in Patients with BRAF V600-Mutant MelanomaMichael Weichenthal, Dirk Debus, Lisa Zimmer, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 6, 2017
Intervalltherapie mit Vemurafenib beim malignen MelanomNicolai Treiber, Margit Anna Huber, Lars Alexander Schneider, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2004
T cell recognition of desmoglein 3 peptides in patients with pemphigus vulgaris and healthy individualsChristian M Veldman, Kerstin L Gebhard, Wolfgang Uter, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 12, 2023
VEXAS-Syndrome, a newly described autoinflammatory systemic disease with dermatologic manifestationsVera Baur, Johanna Stoevesandt, Axel Hueber, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 12, 2023
VEXAS-Syndrom, eine neu beschriebene autoinflammatorische Systemerkrankung mit dermatologischen ManifestationenVera Baur, Johanna Stoevesandt, Axel Hueber, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 16, 2026
Multibacillary Leprosy - a diagnostic and therapeutic challengeVera Baur, Christoph Lange, Axel Hueber, et al.
Melanoma Research|November 10, 2007
Targeted combined anti-inflammatory and angiostatic therapy in advanced melanoma: a randomized phase II trialAlbrecht Reichle, Thomas Vogt, Brigitte Coras, et al.
American Journal of Clinical Dermatology|November 14, 2024
Intravenous Immunoglobulin Therapy for Pyoderma Gangrenosum: A Multicenter Retrospective Analysis in 81 PatientsMoritz Ronicke, Lukas Sollfrank, Martin V Vitus, et al.
JCI Insight|April 20, 2017
Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patientsStefanie Gross, Michael Erdmann, Ina Haendle, et al.
Annals of Surgical Oncology|February 23, 2017
The Impact of Smoking on Sentinel Node Metastasis of Primary Cutaneous MelanomaMaris S Jones, Peter C Jones, Stacey L Stern, et al.
Cancers|February 27, 2026
COMBI-EU: Real-World Evidence on Adverse Event Management and Time on Therapy with Adjuvant Dabrafenib Plus Trametinib in Patients with BRAF V600-Mutant MelanomaMichael Weichenthal, Dirk Debus, Lisa Zimmer, et al.
Pageof 3